Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Imipenem

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,418Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck defends antibiotic's approval from 2019
    Merck defends antibiotic's approval from 2019

    17 May 2023

    // Zachary Brennan ENDPTS

    https://endpts.com/merck-defends-antibiotics-approval-from-2019-as-bmj-investigation-points-to-decline-in-fda-standards/

    Zachary Brennan ENDPTS
    17 May 2023
    Share Share
    Enforcement Report - Week of February 22, 2023
    Enforcement Report - Week of February 22, 2023

    22 Feb 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf

    FDA
    22 Feb 2023
    Share Share
    Merck is shutting the doors at a 300-person plant in PA
    Merck is shutting the doors at a 300-person plant in PA

    25 Mar 2022

    // F. Kansteiner FIERCEPHARMA

    https://www.fiercepharma.com/pharma/merck-telegraphs-closure-pa-antibiotics-plant-employs-300

    F. Kansteiner FIERCEPHARMA
    25 Mar 2022
    Share Share
    Novel antibiotic Recarbrio has launched in the UK
    Novel antibiotic Recarbrio has launched in the UK

    20 Nov 2020

    // PHARMATIMES

    http://www.pharmatimes.com/news/novel_antibiotic_recarbrio_has_launched_in_the_uk_1357341

    PHARMATIMES
    20 Nov 2020
    Share Share
    FDA Approves Merck’s (imipenem, cilastatin, and relebactam) for the Treatment
    FDA Approves Merck’s (imipenem, cilastatin, and relebactam) for the Treatment

    05 Jun 2020

    // MERCK

    https://investors.merck.com/news/press-release-details/2020/FDA-Approves-Mercks-RECARBRIO-imipenem-cilastatin-and-relebactam-for-the-Treatment-of-Adults-with-Hospital-Acquired-and-Ventilator-Associated-Bacterial-Pneumonia-HABPVABP/default.aspx

    MERCK
    05 Jun 2020
    Share Share
    Results of Ph 3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™
    Results of Ph 3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™

    06 May 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200506005158/en

    BUSINESSWIRE
    06 May 2020
    Share Share